Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study: An Open Prospective Study of the Safety and Effectiveness of Aripiprazole in the Treatment of Bipolar Depression

NCT00226317 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT00226317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study: An Open Prospective Study of the Safety and Effectiveness of Aripiprazole in the Treatment of Bipolar Depression
Lead sponsor
Cambridge Health Alliance
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2004
Completion date
February 29, 2008
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder